Clinical trial
24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
NCT03478761 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 24-Hydroxylase Deficiency and CYP24A1 Mutation Patient Registry
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 19, 2017
- Completion date
- December 31, 2030
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
24-hydroxylase deficiency